SARS-CoV-2 Delta VOC in Scotland: demographics, risk of hospital admission, and vaccine effectiveness.

Sheikh, Aziz; McMenamin, Jim; Taylor, Bob; Robertson, Chris

Sheikh, Aziz; McMenamin, Jim; Taylor, Bob; Robertson, Chris.

Sheikh A; Usher Institute, University of Edinburgh, Edinburgh EH8 9AG, UK. Electronic address: aziz.sheikh@ed.ac.uk.
McMenamin J; Public Health Scotland, Glasgow, UK.
Taylor B; Public Health Scotland, Glasgow, UK.
Robertson C; Public Health Scotland, Glasgow, UK.

Lancet ; 397(10293): 2461-2462, 2021 06 26.

Article in English | MEDLINE | ID: covidwho-1267971

Subject(s)

COVID-19 Vaccines; COVID-19/prevention & control; COVID-19/virology; Patient Admission/statistics & numerical data; SARS-CoV-2; Vaccination/statistics & numerical data; Aged; COVID-19/epidemiology; Child; Child, Preschool; Humans; Population Surveillance; SARS-CoV-2/genetics; SARS-CoV-2/isolation & purification; Scotland/epidemiology

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Patient Admission / Vaccination / COVID-19 Vaccines / SARS-CoV-2 / COVID-19 Type of study: Experimental Studies / Observational study / Prognostic study Topics: Vaccines / Variants Limits: Aged / Child / Child, preschool / Humans Country/Region as subject: Europa Language: English Journal: Lancet Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google